Patent Strategy Before Your Series A: A San Diego Startup Founder's Guide to IP, Timing, and Investor Readiness
A patent strategy is one of the most overlooked fundraising tools available to pre-funding startups. Filing patent applications before you raise capital isn't just about legal protection — it's a signal to investors that your technology is defensible, your team is thinking long-term, and your company is worth a premium valuation. For founders in San Diego and across Southern California, where the startup ecosystem spans biotech, SaaS, AI, defense tech, and cleantech, getting your IP house in order before you walk into a pitch meeting can be the difference between a term sheet and a pass.
This guide breaks down how to build a patent strategy that supports your fundraise — what to file, when to file, what it costs, and what investors actually look for during IP due diligence.
Why Do Investors Care About Patents?
Investors care about patents because patents reduce risk. When a venture capitalist or angel investor evaluates a startup, one of the first questions they ask is: Can someone else just build the same thing? A patent — or even a pending patent application — tells them you've taken steps to prevent that.
The data backs this up. A joint study by the European Patent Office and the European Union Intellectual Property Office found that startups with patent filings before an early growth round were more than six times as likely to secure funding as those without any IP filings. PitchBook's 2023 patent research — which analyzed thousands of U.S. VC-backed startups from 2011 to 2022 — found that startups with patents consistently raised capital at higher valuations than those without, with the valuation gap widening at later stages: roughly 17% higher at seed, 30% higher at the early stage, and over 50% higher at the late stage. Patent-holding startups also achieved average exit values 2.1 times larger than non-patent peers, and were nearly six times more likely to exit via IPO rather than acquisition.
The signaling effect is especially powerful for first-time founders and companies outside of major startup hubs like the Bay Area. If you don't have a famous co-founder or a prior relationship with a top-tier VC, patents serve as a credibility marker that levels the playing field. For San Diego founders — where the ecosystem is strong but still competing for attention against Silicon Valley — this kind of signal matters.
The bottom line: Patents aren't just legal documents. They're fundraising assets.
Do I Need a Patent Before Raising a Series A?
You don't necessarily need a granted patent before your Series A, but you should have at least one patent application on file — ideally a provisional application at minimum.
Here's why. The patent process takes time. A typical utility patent application takes two to four years to be examined and granted by the USPTO. But investors don't expect you to have a granted patent at the seed or Series A stage. What they expect is evidence that you've started the process — that your core technology is protected, your priority date is established, and you can credibly say "patent pending."
Empirical research confirms that most startups file early. Of all startups that eventually patent, roughly 56% file their first patent application before raising a seed or Series A round. Another 28% file shortly after their first round. Very few wait beyond a Series B — by that point, if a company hasn't filed, it likely never will.
The reason so many founders file before fundraising is straightforward: a pending patent application gives you something concrete to discuss in investor meetings, it protects your ability to speak freely about your technology without destroying patentability, and it demonstrates strategic thinking about long-term competitive advantage.
The Pre-Disclosure Trap: Don't Destroy Your Own Patent Rights
This is the mistake we see most often with San Diego startups, and it's the most preventable.
If you publicly disclose your invention before filing a patent application, you may lose the right to patent it. In the United States, there is a one-year grace period after a public disclosure, but most foreign jurisdictions offer no grace period at all. Once your invention is public, your international filing options can be permanently foreclosed.
Public disclosure happens more easily than founders realize. Common ways startups accidentally destroy their own patent rights include:
Pitch decks that describe how the technology works, shared with investors who haven't signed an NDA
Demo days and accelerator presentations at programs like EvoNexus, Techstars San Diego, or Y Combinator
Published GitHub repositories that expose the technical implementation
Conference talks or academic publications — especially common for UCSD spinouts and founders from Scripps Research or the Salk Institute
Product launches or beta programs where the technology is described publicly on a website or in marketing materials
The practical takeaway is simple: file before you share. At a minimum, get a provisional patent application on file before your first investor meeting, your first demo day, or your first public product announcement. A provisional application is relatively inexpensive, establishes your priority date, and gives you 12 months to follow up with a full utility application.
If you've already disclosed, don't panic — but talk to a patent attorney immediately. There may still be options available depending on when the disclosure happened and which jurisdictions you care about.
What's the Difference Between a Provisional, Non-Provisional, and PCT Application?
One of the most common questions we get from San Diego startup founders is which type of patent application to file first. Here's a straightforward comparison:
| Provisional Application | Non-Provisional (Utility) Application | PCT International Application | |
|---|---|---|---|
| What it does | Establishes a priority date and “patent pending” status | Starts the formal examination process at the USPTO | Preserves the right to file in 150+ countries |
| Duration | Expires after 12 months (must convert or it lapses) | Examined by USPTO; typically 2–4 years to grant | Up to 30 months from priority date before national phase deadlines |
| Initial cost | $2,000 – $5,000 including attorney fees; USPTO fees are minimal | $8,000 – $15,000+ including attorney fees and USPTO fees | $4,000 – $8,000 for initial filing; national phase costs vary by country |
| Total cost to grant | N/A — must convert to a non-provisional or PCT to result in an issued patent | $15,000 – $30,000+ including office action responses, issue fee, and USPTO fees over the life of prosecution | Varies widely by country; budget for translation, local counsel, and national phase filing fees in each jurisdiction |
| Best for | Early-stage startups still iterating on the technology | Startups with stable technology ready for full prosecution | Startups with international markets or acquirers in mind |
| Investor signal | Shows you’ve started the process | Strongest domestic signal; moves toward granted patent | Signals global ambition and strategic sophistication |
For most pre-funding startups, the right first move is a provisional application. It's the lowest-cost way to establish your priority date, it gives you "patent pending" status for investor conversations, and it buys you 12 months to refine the invention and raise capital before committing to the larger expense of a full utility filing or international PCT application.
A staged approach works well: file a provisional when the core technical concept is stable, then use the 12-month window to refine and add embodiments based on real-world implementation. When you convert to a non-provisional or file a PCT, you'll have a stronger application because it reflects the technology as it actually works — not just as it was originally conceived.
What Does IP Due Diligence Look Like From the Investor's Side?
Understanding what investors look for during IP due diligence helps you anticipate questions before they come up. The depth of review varies significantly — a seed-stage angel investor may only ask whether you've filed anything, while a Series A lead with a dedicated legal team may conduct a structured review. What follows are the areas that tend to surface most often, though not every startup will face all of them.
Ownership and assignment is the issue that creates the most problems, and it's often the easiest to prevent. Investors want to confirm that the company — not individual founders — owns the IP. This becomes complicated when early development involved freelancers, co-founders who have since departed, or work done during a university affiliation. For San Diego startups that originated at UCSD, Scripps Research, or the Salk Institute, the underlying license agreement with the institution's tech transfer office often comes under scrutiny. If your startup has any of these dynamics, it's worth understanding early whether the chain of title is clean, because a gap here can slow down or derail a round.
Patent portfolio scope matters more to some investors than others. In patent-intensive industries like biotech and medical devices, investors may want to understand whether the claims in your applications actually cover the products generating (or expected to generate) revenue. In software and SaaS, the inquiry is often lighter — investors may care more about whether you've filed at all than about claim-by-claim analysis. The point isn't that every startup needs a portfolio audit, but that the further you get into fundraising, the more likely it is that someone on the investor side will ask questions about what your filings actually protect.
Freedom to operate is another area that comes up, though how much attention it gets depends on the competitive landscape. If you're operating in a space with large incumbents who hold broad patent portfolios — common in medical devices, telecom, and certain areas of enterprise software — an investor may want to know whether you've at least considered the risk of infringement. A full FTO analysis isn't always necessary or cost-effective at the pre-funding stage, but being able to demonstrate awareness of the landscape goes a long way.
Prosecution status and housekeeping can surface as well, particularly if your filings have been pending for a while. Investors may ask whether there are outstanding office actions, missed deadlines, or lapsed applications. None of these are unusual on their own — office actions are a normal part of prosecution — but a pattern of missed deadlines can signal operational issues that make investors uncomfortable.
Trade secret and confidentiality practices are occasionally reviewed, especially if the startup's competitive advantage depends partly on proprietary know-how rather than patents alone. This is less about having a perfect system and more about whether the company has been reasonably disciplined — NDAs with key partners, confidentiality clauses in employment agreements, and some degree of care about what's been shared publicly.
The broader point is that IP due diligence isn't a standardized test with a pass/fail score. It's a conversation, and the specifics depend on your industry, your stage, and the investor sitting across from you. But the founders who walk into that conversation prepared — with clean ownership, a clear filing history, and thoughtful answers about their IP strategy — consistently come out ahead.
A Practical Patent Filing Timeline for Pre-Funding Startups
Here's a practical sequence that maps patent milestones to the fundraising process. Every startup moves at its own pace, so think of these as phases rather than a fixed calendar.
Phase 1: Foundation (Before You Talk to Anyone) Begin working with a patent attorney to identify your core patentable technology. Conduct a preliminary prior art search to understand the landscape. Get invention assignment agreements signed by all founders, employees, and contractors. If you're licensing technology from a university or research institution, make sure those agreements are executed. This phase is about getting your house in order before any external conversations begin.
Phase 2: First Filing (Before Investor Outreach) File one or more provisional patent applications covering your core technology. This gets you "patent pending" status before you begin talking to investors, presenting at demo days, or sharing detailed pitch decks. Update your data room to reference the filings. The key principle here is simple: file before you share.
Phase 3: Fundraise (With IP in Place) Enter investor conversations with a clean IP story: provisional applications on file, assignments recorded, and a clear plan for full prosecution after funding. Use part of the raise to budget for converting provisionals to non-provisional utility applications and, if appropriate, PCT international filings.
Phase 4: Post-Close (Execute the Plan) Convert provisional applications to non-provisional or PCT before the 12-month provisional deadline expires. Begin thinking about continuation applications or additional filings based on product development since the original provisional. Consider design patent applications for distinctive product aesthetics or UI elements.
The phases are sequential, but the timing between them depends on your specific situation — how developed the technology is, how quickly you're moving toward investor conversations, and how complex the IP landscape is in your space. The key principle is consistent: file before you fundraise, and have a plan for what comes after.
How Much Does a Patent Cost for a Startup?
Cost is one of the biggest concerns for pre-funding startups, and understandably so. Here's a realistic picture of what patent prosecution costs at each stage:
Provisional patent application: Typically $2,000 to $5,000 in attorney fees, plus modest USPTO filing fees (see the USPTO fee schedule for current rates). This is the most budget-friendly entry point.
Non-provisional utility patent application: Typically $8,000 to $15,000+ in attorney fees depending on complexity, plus USPTO filing and search fees. Costs rise with the complexity of the technology and the breadth of the claims.
PCT international application: Typically $4,000 to $8,000 for the initial filing. The larger expense comes later, at the national phase stage (around month 30), when you select specific countries and pay translation and local filing fees.
What many founders don't anticipate is the cost of ongoing prosecution. Filing the application is just the beginning. After the USPTO examiner reviews your application, they will almost always issue at least one office action — a formal rejection or objection that requires a written response. Most applications go through two or three rounds of this back-and-forth before reaching allowance, and some take more. Each office action response typically costs $2,000 to $5,000 in attorney fees, plus any USPTO fees for extensions of time if you need additional time to respond. There's also an issue fee due when the patent is finally allowed, and maintenance fees at 3.5, 7.5, and 11.5 years after grant to keep the patent in force. All of this means that the total cost of getting a single U.S. patent from filing to grant — including the initial application, office action responses, and the issue fee — commonly runs $15,000 to $30,000 or more over the life of prosecution. It's important to plan for these costs rather than thinking of the initial filing fee as the entire expense.
One thing that helps with costs: The USPTO offers reduced fees for "small entities," which includes companies with fewer than 500 employees. Small entity fees are roughly 60% less than the standard large entity rates, and most startups qualify. A staged filing approach also lets you spread costs over time and make decisions about which applications to continue prosecuting based on how the business evolves.
We always tell founders: budget for IP in your fundraising plan. Investors expect to see patent costs in your use-of-funds breakdown — it signals that you're serious about protecting the technology they're investing in. These ranges are general estimates — every project is different depending on the complexity of the technology, the number of inventions, and your international filing goals. If you'd like a quote for your specific situation, book a consultation.
San Diego and Southern California: Why Local Context Matters
San Diego's startup ecosystem has its own IP dynamics that are worth understanding. The region raised $3.37 billion in startup funding in 2024 and ranks among the top 10 U.S. startup ecosystems. The sectors that dominate here — biotech and life sciences, AI, defense tech, SaaS, and cleantech — are all patent-intensive.
A few things specific to the San Diego and Southern California startup landscape:
University spinouts require careful IP planning. If your startup originated at UCSD, Scripps Research, Salk Institute, or another research institution, you likely have a license agreement governing the underlying IP. Investors will scrutinize these agreements closely. Make sure the terms are clear, the license is exclusive (or has the right scope), and the relationship with the tech transfer office is documented.
Biotech and life sciences companies often need broader portfolios. In pharma and medical devices, patent portfolios are central to company valuation. A single strong patent family can be the entire basis for a company's value. Filing strategies here tend to be more aggressive and more international from the start.
Software and SaaS patents require careful claim drafting. Since the Alice v. CLS Bank decision in 2014, software-related patent claims must be drafted to avoid being rejected as abstract ideas. This is an area where working with a patent attorney who understands software prosecution — and how to draft claims that satisfy Section 101 requirements — matters significantly.
The local investor community pays attention to IP. Organizations like NuFund Venture Group, Tech Coast Angels, and the San Diego Venture Group are all active in the region, and many of their members come from patent-intensive industries. A clean IP story plays well with these groups.
Frequently Asked Questions
What is a provisional patent application? A provisional patent application is a filing with the USPTO that establishes a priority date for your invention without starting the formal examination process. It lasts 12 months, during which you can use "patent pending" status. It must be followed by a non-provisional application to result in an issued patent.
Can I file a patent myself to save money? Technically, yes — the USPTO allows "pro se" filings. But patent applications are legal documents with highly specific requirements, and errors in claim drafting or specification language can permanently limit the scope of your protection. For startups planning to raise capital, the quality of the patent application matters, and investors will notice the difference. Working with a registered patent attorney is strongly recommended.
How long does it take to get a patent? A typical utility patent takes two to four years from filing to grant, though it can be faster with prioritized examination programs like Track One (which costs more but can yield a decision within 12 months). For fundraising purposes, you don't need a granted patent — a pending application with a solid priority date is sufficient at the seed and Series A stages.
What's the difference between a patent and a trade secret? A patent is a public document that grants you the exclusive right to prevent others from practicing your invention for up to 20 years. A trade secret is confidential information (like a manufacturing process, algorithm, or formula) that derives value from being kept secret. Not every innovation should be patented — some are better protected as trade secrets. A patent attorney can help you evaluate which approach makes sense for each piece of your technology.
Do I need international patent protection? It depends on your market and exit strategy. If your customers, competitors, or potential acquirers operate internationally, then yes — international protection is worth considering. The PCT (Patent Cooperation Treaty) route gives you up to 30 months from your original filing date to decide which countries to enter, which aligns well with the fundraising timeline for most startups.
What if I've already disclosed my invention publicly? In the United States, you have a one-year grace period from the date of public disclosure to file a patent application. However, most foreign jurisdictions have no grace period at all. If you've disclosed publicly and haven't filed yet, contact a patent attorney right away to understand what options remain.
Ready to Build Your Patent Strategy?
At Lynch LLP, we work with startup founders across San Diego, Orange County, Los Angeles, and throughout Southern California to build patent strategies that support fundraising, protect core technology, and position companies for long-term growth. Whether you're pre-seed and thinking about your first provisional filing or preparing for Series A due diligence, we can help.
Book a free consultation to discuss your startup's IP strategy.
This post is an advertisement for legal services. It is provided for general information purposes only and may not be relied upon as legal advice. Sean Lynch is a licensed lawyer in California and before the USPTO and is responsible for this content. You can reach Sean at contact at lynchllp.com.